News Aprazer Healthcare Launched Indenza September 29, 2021 Posted by Aprazer 13 Jul 2020 Launch Date: 13-07-2020 Aprazer Healthcare Launched INDENZA ( ENZULATAMIDE ) which is a medication indicated for the treatment of castration-resistant prostate cancer (CRPC) and metastatic castration-sensitive prostate cancer (mCSPC) .